🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
“Ten years ago I was kicked out and forced to retire.”
Our new medicine laureate Katalin Karikó (@kkariko) told us how much it means to be awarded the Nobel Prize after a scientific career that has been full of challenges.
Ten years ago, Karikó was still doing all her experiments by hand but today she has been awarded the medicine prize for her research on mRNA, which led to the development of COVID-19 vaccines.
Listen now:
Had a blast interviewing @themicrobeguy at our @SkyDeck_Cal x @a16zBioHealth student mixer last night. From spotting a synthetic biology flyer in undergrad to quickly becoming a trailblazing scientist-entrepreneur in that field -- what a remarkable journey it's been 🚀@UCBerkeley
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
Latest CRISPR news -> shorturl.at/fDIS7
🚀Amber Bio launches with an oversubscribed $26M seed financing round, which will be used to develop RNA-editing therapies for previously undruggable diseases. Co-founded by Basem Al-Shayeb, Ph.D. & Jacob Borrajo, & they are #hiring
We're on a mission to develop intrepid new approaches to RNA medicines. Towards commercialization, we’ve announced the launch of Amber Bio this ~AUG~, with funding from visionary teams at @Playground_VC, @a16z, @EliLillyandCo & more. If this work interests you, we're hiring!
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
Excited to share our recent study describing a new gene editing approach capable of extensive multi-kilobase edits. When DNA is giving you problems look into the RNA. Much more to come, so stay tuned. biorxiv.org/content/10.1101/…
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n)
biorxiv.org/content/10.1101/…
Since RNA is a highly regulated molecule in the cell, the levels of a target RNA would also be under endogenous cellular control, and one could more easily maintain natural transcriptional levels to make the right levels of protein at the right time (12/n)
Many genes, like USH2A above, are too large for traditional gene therapy, and too heterogenous for existing gene editing methods. Using our approach, one may replace several exons at once at the 5’ or 3’ end of an RNA, or replace one or more internal exons (13/n)